Xtant Medical Holdings, Inc. (XTNT) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 12, 2025, announces the financial results for Xtant Medical Holdings, Inc. for the three months ended March 31, 2025 (First Quarter 2025). The full details of the results are contained in the press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of the results and a disclosure of the company's methodology for calculating non-GAAP measures.
The Company utilizes non-GAAP adjusted EBITDA as a supplemental measure to assess core operational performance. This metric is defined as net income (loss) adjusted to exclude:
- Depreciation and amortization expense
- Interest expense and tax benefit (expense)
- Separation-related expenses
- Non-cash compensation
- Acquisition-related expenses and fair value adjustments
- Unrealized foreign currency translation gain or loss
Material Changes and Management Commentary
The filing does not detail specific material changes in financial position compared to prior periods, as the quantitative data is located in the attached press release (Exhibit 99.1). Management commentary within this filing focuses on the rationale for using non-GAAP adjusted EBITDA:
- Operational Focus: Management believes the measure provides meaningful information regarding core operational performance by factoring out charges not related to regular, ongoing business.
- Resource Allocation: The metric aids in budgeting and spending decisions across sales, marketing, general and administrative, and research and development expenses.
- Comparability: Excluding items like separation costs and non-cash compensation facilitates period-over-period comparisons and comparisons with peer companies.
Risks and Contingencies
The filing includes standard disclosures regarding the limitations of non-GAAP financial measures:
- Non-GAAP measures are not in accordance with GAAP and may differ from measures used by other companies.
- They do not reflect all amounts associated with financial results as determined under GAAP.
- Investors are cautioned to use these measures only in conjunction with the corresponding GAAP measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2025 revenue, net income, and cash flow figures.
- Verify the reconciliation table between GAAP net income and non-GAAP adjusted EBITDA in the press release.
- Assess the magnitude of excluded items (e.g., separation-related expenses, non-cash compensation) to understand their impact on reported profitability.
- Compare Q1 2025 results against Q1 2024 figures provided in the press release to confirm year-over-year trends.